nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—BCHE—diaphragm—ovarian cancer	0.0852	0.296	CbGeAlD
Ephedrine—Etomidate—SLC2A1—ovarian cancer	0.0382	0.74	CrCbGaD
Ephedrine—Nasal dryness—Paclitaxel—ovarian cancer	0.0162	0.0298	CcSEcCtD
Ephedrine—SLC18A2—uterine cervix—ovarian cancer	0.016	0.0555	CbGeAlD
Ephedrine—SLC18A2—endometrium—ovarian cancer	0.0144	0.0502	CbGeAlD
Ephedrine—Vertigo—Altretamine—ovarian cancer	0.0138	0.0254	CcSEcCtD
Ephedrine—SLC18A2—uterus—ovarian cancer	0.0133	0.0463	CbGeAlD
Ephedrine—SLC18A2—female reproductive system—ovarian cancer	0.012	0.0416	CbGeAlD
Ephedrine—Anorexia—Altretamine—ovarian cancer	0.012	0.022	CcSEcCtD
Ephedrine—Pseudoephedrine—IL2—ovarian cancer	0.0119	0.23	CrCbGaD
Ephedrine—Decreased appetite—Altretamine—ovarian cancer	0.0109	0.0201	CcSEcCtD
Ephedrine—SLC18A2—vagina—ovarian cancer	0.0108	0.0376	CbGeAlD
Ephedrine—BCHE—myometrium—ovarian cancer	0.0104	0.036	CbGeAlD
Ephedrine—ACHE—testis—ovarian cancer	0.00991	0.0345	CbGeAlD
Ephedrine—SLC18A2—testis—ovarian cancer	0.00966	0.0336	CbGeAlD
Ephedrine—SLC6A2—decidua—ovarian cancer	0.00929	0.0323	CbGeAlD
Ephedrine—ADRA1A—epithelium—ovarian cancer	0.00914	0.0318	CbGeAlD
Ephedrine—Asthenia—Altretamine—ovarian cancer	0.009	0.0166	CcSEcCtD
Ephedrine—Dizziness—Altretamine—ovarian cancer	0.00829	0.0153	CcSEcCtD
Ephedrine—SLC6A2—gonad—ovarian cancer	0.00818	0.0284	CbGeAlD
Ephedrine—BCHE—uterine cervix—ovarian cancer	0.00806	0.028	CbGeAlD
Ephedrine—Vomiting—Altretamine—ovarian cancer	0.00797	0.0147	CcSEcCtD
Ephedrine—Extrasystoles—Paclitaxel—ovarian cancer	0.0076	0.014	CcSEcCtD
Ephedrine—Nausea—Altretamine—ovarian cancer	0.00745	0.0137	CcSEcCtD
Ephedrine—Pain—Carboplatin—ovarian cancer	0.00741	0.0136	CcSEcCtD
Ephedrine—SLC6A2—female reproductive system—ovarian cancer	0.0073	0.0254	CbGeAlD
Ephedrine—BCHE—endometrium—ovarian cancer	0.00729	0.0253	CbGeAlD
Ephedrine—ACHE—lymph node—ovarian cancer	0.00718	0.025	CbGeAlD
Ephedrine—SLC18A2—lymph node—ovarian cancer	0.007	0.0243	CbGeAlD
Ephedrine—Body temperature increased—Carboplatin—ovarian cancer	0.00685	0.0126	CcSEcCtD
Ephedrine—BCHE—uterus—ovarian cancer	0.00671	0.0233	CbGeAlD
Ephedrine—Blood pressure increased—Paclitaxel—ovarian cancer	0.0064	0.0118	CcSEcCtD
Ephedrine—Hallucination—Chlorambucil—ovarian cancer	0.00624	0.0115	CcSEcCtD
Ephedrine—BCHE—female reproductive system—ovarian cancer	0.00604	0.021	CbGeAlD
Ephedrine—Sweating—Topotecan—ovarian cancer	0.00596	0.011	CcSEcCtD
Ephedrine—SLC6A2—testis—ovarian cancer	0.00589	0.0205	CbGeAlD
Ephedrine—Angina pectoris—Vinorelbine—ovarian cancer	0.00581	0.0107	CcSEcCtD
Ephedrine—Lightheadedness—Paclitaxel—ovarian cancer	0.00573	0.0105	CcSEcCtD
Ephedrine—BCHE—bone marrow—ovarian cancer	0.0057	0.0198	CbGeAlD
Ephedrine—BCHE—vagina—ovarian cancer	0.00546	0.019	CbGeAlD
Ephedrine—Blood pressure increased—Docetaxel—ovarian cancer	0.00542	0.00998	CcSEcCtD
Ephedrine—Tremor—Chlorambucil—ovarian cancer	0.00512	0.00942	CcSEcCtD
Ephedrine—Agitation—Chlorambucil—ovarian cancer	0.00502	0.00924	CcSEcCtD
Ephedrine—Arrhythmia—Melphalan—ovarian cancer	0.00489	0.00899	CcSEcCtD
Ephedrine—BCHE—testis—ovarian cancer	0.00487	0.0169	CbGeAlD
Ephedrine—Lightheadedness—Docetaxel—ovarian cancer	0.00485	0.00893	CcSEcCtD
Ephedrine—Muscle spasms—Topotecan—ovarian cancer	0.00467	0.0086	CcSEcCtD
Ephedrine—Confusional state—Chlorambucil—ovarian cancer	0.00449	0.00827	CcSEcCtD
Ephedrine—SLC6A2—lymph node—ovarian cancer	0.00427	0.0149	CbGeAlD
Ephedrine—Arrhythmia—Vinorelbine—ovarian cancer	0.00427	0.00786	CcSEcCtD
Ephedrine—Delirium—Epirubicin—ovarian cancer	0.00425	0.00783	CcSEcCtD
Ephedrine—Anorexia—Chlorambucil—ovarian cancer	0.00425	0.00782	CcSEcCtD
Ephedrine—Chest pain—Topotecan—ovarian cancer	0.00414	0.00762	CcSEcCtD
Ephedrine—Chest pain—Melphalan—ovarian cancer	0.00405	0.00746	CcSEcCtD
Ephedrine—Delirium—Doxorubicin—ovarian cancer	0.00394	0.00724	CcSEcCtD
Ephedrine—Dyspepsia—Chlorambucil—ovarian cancer	0.00392	0.00722	CcSEcCtD
Ephedrine—Decreased appetite—Chlorambucil—ovarian cancer	0.00387	0.00713	CcSEcCtD
Ephedrine—Hyperhidrosis—Topotecan—ovarian cancer	0.00384	0.00706	CcSEcCtD
Ephedrine—Pain—Chlorambucil—ovarian cancer	0.00381	0.00701	CcSEcCtD
Ephedrine—Tachycardia—Melphalan—ovarian cancer	0.00379	0.00698	CcSEcCtD
Ephedrine—Anorexia—Topotecan—ovarian cancer	0.00378	0.00696	CcSEcCtD
Ephedrine—Dysuria—Paclitaxel—ovarian cancer	0.00375	0.00691	CcSEcCtD
Ephedrine—Vertigo—Vinorelbine—ovarian cancer	0.00374	0.00688	CcSEcCtD
Ephedrine—Anorexia—Melphalan—ovarian cancer	0.0037	0.00682	CcSEcCtD
Ephedrine—Palpitations—Vinorelbine—ovarian cancer	0.00368	0.00676	CcSEcCtD
Ephedrine—Feeling abnormal—Chlorambucil—ovarian cancer	0.00367	0.00676	CcSEcCtD
Ephedrine—Hypertension—Vinorelbine—ovarian cancer	0.00359	0.00661	CcSEcCtD
Ephedrine—Chest pain—Vinorelbine—ovarian cancer	0.00354	0.00652	CcSEcCtD
Ephedrine—Dyspnoea—Topotecan—ovarian cancer	0.00354	0.00651	CcSEcCtD
Ephedrine—BCHE—lymph node—ovarian cancer	0.00353	0.0123	CbGeAlD
Ephedrine—Body temperature increased—Chlorambucil—ovarian cancer	0.00352	0.00648	CcSEcCtD
Ephedrine—Dyspepsia—Topotecan—ovarian cancer	0.00349	0.00643	CcSEcCtD
Ephedrine—Dyspnoea—Melphalan—ovarian cancer	0.00346	0.00637	CcSEcCtD
Ephedrine—Decreased appetite—Topotecan—ovarian cancer	0.00345	0.00635	CcSEcCtD
Ephedrine—Dyspepsia—Melphalan—ovarian cancer	0.00342	0.00629	CcSEcCtD
Ephedrine—Pain—Topotecan—ovarian cancer	0.00339	0.00624	CcSEcCtD
Ephedrine—Decreased appetite—Melphalan—ovarian cancer	0.00338	0.00622	CcSEcCtD
Ephedrine—Pain—Melphalan—ovarian cancer	0.00332	0.00611	CcSEcCtD
Ephedrine—Angina pectoris—Docetaxel—ovarian cancer	0.00331	0.0061	CcSEcCtD
Ephedrine—Tachycardia—Vinorelbine—ovarian cancer	0.00331	0.0061	CcSEcCtD
Ephedrine—Bradycardia—Paclitaxel—ovarian cancer	0.00327	0.00602	CcSEcCtD
Ephedrine—Feeling abnormal—Topotecan—ovarian cancer	0.00327	0.00602	CcSEcCtD
Ephedrine—Anorexia—Vinorelbine—ovarian cancer	0.00324	0.00595	CcSEcCtD
Ephedrine—Asthenia—Chlorambucil—ovarian cancer	0.0032	0.00589	CcSEcCtD
Ephedrine—Body temperature increased—Topotecan—ovarian cancer	0.00314	0.00577	CcSEcCtD
Ephedrine—Dyspnoea—Vinorelbine—ovarian cancer	0.00303	0.00557	CcSEcCtD
Ephedrine—Decreased appetite—Vinorelbine—ovarian cancer	0.00295	0.00543	CcSEcCtD
Ephedrine—Pain—Vinorelbine—ovarian cancer	0.0029	0.00534	CcSEcCtD
Ephedrine—Arrhythmia—Paclitaxel—ovarian cancer	0.00287	0.00528	CcSEcCtD
Ephedrine—Asthenia—Topotecan—ovarian cancer	0.00285	0.00524	CcSEcCtD
Ephedrine—Vomiting—Chlorambucil—ovarian cancer	0.00283	0.00522	CcSEcCtD
Ephedrine—Feeling abnormal—Vinorelbine—ovarian cancer	0.0028	0.00515	CcSEcCtD
Ephedrine—Asthenia—Melphalan—ovarian cancer	0.00279	0.00513	CcSEcCtD
Ephedrine—Tension—Paclitaxel—ovarian cancer	0.00274	0.00505	CcSEcCtD
Ephedrine—Nervousness—Paclitaxel—ovarian cancer	0.00272	0.005	CcSEcCtD
Ephedrine—Muscle spasms—Paclitaxel—ovarian cancer	0.00269	0.00495	CcSEcCtD
Ephedrine—Body temperature increased—Vinorelbine—ovarian cancer	0.00268	0.00494	CcSEcCtD
Ephedrine—Nausea—Chlorambucil—ovarian cancer	0.00265	0.00487	CcSEcCtD
Ephedrine—Dizziness—Topotecan—ovarian cancer	0.00262	0.00483	CcSEcCtD
Ephedrine—Tremor—Paclitaxel—ovarian cancer	0.00262	0.00482	CcSEcCtD
Ephedrine—Agitation—Paclitaxel—ovarian cancer	0.00257	0.00473	CcSEcCtD
Ephedrine—Vomiting—Topotecan—ovarian cancer	0.00252	0.00464	CcSEcCtD
Ephedrine—Vertigo—Paclitaxel—ovarian cancer	0.00251	0.00463	CcSEcCtD
Ephedrine—Rash—Topotecan—ovarian cancer	0.0025	0.0046	CcSEcCtD
Ephedrine—Dermatitis—Topotecan—ovarian cancer	0.0025	0.0046	CcSEcCtD
Ephedrine—Headache—Topotecan—ovarian cancer	0.00249	0.00457	CcSEcCtD
Ephedrine—Palpitations—Paclitaxel—ovarian cancer	0.00247	0.00455	CcSEcCtD
Ephedrine—Vomiting—Melphalan—ovarian cancer	0.00247	0.00455	CcSEcCtD
Ephedrine—Rash—Melphalan—ovarian cancer	0.00245	0.00451	CcSEcCtD
Ephedrine—Dermatitis—Melphalan—ovarian cancer	0.00245	0.0045	CcSEcCtD
Ephedrine—Asthenia—Vinorelbine—ovarian cancer	0.00244	0.00448	CcSEcCtD
Ephedrine—Arrhythmia—Docetaxel—ovarian cancer	0.00243	0.00448	CcSEcCtD
Ephedrine—Hypertension—Paclitaxel—ovarian cancer	0.00242	0.00444	CcSEcCtD
Ephedrine—Chest pain—Paclitaxel—ovarian cancer	0.00238	0.00438	CcSEcCtD
Ephedrine—Anxiety—Paclitaxel—ovarian cancer	0.00237	0.00437	CcSEcCtD
Ephedrine—Nausea—Topotecan—ovarian cancer	0.00236	0.00434	CcSEcCtD
Ephedrine—Nausea—Melphalan—ovarian cancer	0.00231	0.00425	CcSEcCtD
Ephedrine—Confusional state—Paclitaxel—ovarian cancer	0.0023	0.00424	CcSEcCtD
Ephedrine—Muscle spasms—Docetaxel—ovarian cancer	0.00228	0.0042	CcSEcCtD
Ephedrine—Dizziness—Vinorelbine—ovarian cancer	0.00224	0.00413	CcSEcCtD
Ephedrine—Angina pectoris—Epirubicin—ovarian cancer	0.00224	0.00411	CcSEcCtD
Ephedrine—Tachycardia—Paclitaxel—ovarian cancer	0.00223	0.0041	CcSEcCtD
Ephedrine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00221	0.00406	CcSEcCtD
Ephedrine—Anorexia—Paclitaxel—ovarian cancer	0.00218	0.00401	CcSEcCtD
Ephedrine—Vomiting—Vinorelbine—ovarian cancer	0.00216	0.00397	CcSEcCtD
Ephedrine—Dysuria—Epirubicin—ovarian cancer	0.00215	0.00395	CcSEcCtD
Ephedrine—Rash—Vinorelbine—ovarian cancer	0.00214	0.00394	CcSEcCtD
Ephedrine—Dermatitis—Vinorelbine—ovarian cancer	0.00214	0.00394	CcSEcCtD
Ephedrine—Headache—Vinorelbine—ovarian cancer	0.00213	0.00391	CcSEcCtD
Ephedrine—Palpitations—Docetaxel—ovarian cancer	0.0021	0.00386	CcSEcCtD
Ephedrine—Angina pectoris—Doxorubicin—ovarian cancer	0.00207	0.00381	CcSEcCtD
Ephedrine—Insomnia—Paclitaxel—ovarian cancer	0.00206	0.0038	CcSEcCtD
Ephedrine—Hypertension—Docetaxel—ovarian cancer	0.00205	0.00377	CcSEcCtD
Ephedrine—Dyspnoea—Paclitaxel—ovarian cancer	0.00204	0.00375	CcSEcCtD
Ephedrine—Chest pain—Docetaxel—ovarian cancer	0.00202	0.00372	CcSEcCtD
Ephedrine—Nausea—Vinorelbine—ovarian cancer	0.00202	0.00371	CcSEcCtD
Ephedrine—Dyspepsia—Paclitaxel—ovarian cancer	0.00201	0.0037	CcSEcCtD
Ephedrine—Dysuria—Doxorubicin—ovarian cancer	0.00199	0.00365	CcSEcCtD
Ephedrine—Decreased appetite—Paclitaxel—ovarian cancer	0.00198	0.00365	CcSEcCtD
Ephedrine—Sweating—Epirubicin—ovarian cancer	0.00196	0.00361	CcSEcCtD
Ephedrine—Pain—Paclitaxel—ovarian cancer	0.00195	0.00359	CcSEcCtD
Ephedrine—Confusional state—Docetaxel—ovarian cancer	0.00195	0.00359	CcSEcCtD
Ephedrine—Tachycardia—Docetaxel—ovarian cancer	0.00189	0.00348	CcSEcCtD
Ephedrine—Feeling abnormal—Paclitaxel—ovarian cancer	0.00188	0.00346	CcSEcCtD
Ephedrine—Bradycardia—Epirubicin—ovarian cancer	0.00187	0.00344	CcSEcCtD
Ephedrine—Anorexia—Docetaxel—ovarian cancer	0.00184	0.00339	CcSEcCtD
Ephedrine—Sweating—Doxorubicin—ovarian cancer	0.00182	0.00334	CcSEcCtD
Ephedrine—Body temperature increased—Paclitaxel—ovarian cancer	0.0018	0.00332	CcSEcCtD
Ephedrine—Insomnia—Docetaxel—ovarian cancer	0.00175	0.00322	CcSEcCtD
Ephedrine—Bradycardia—Doxorubicin—ovarian cancer	0.00173	0.00318	CcSEcCtD
Ephedrine—Dyspnoea—Docetaxel—ovarian cancer	0.00173	0.00318	CcSEcCtD
Ephedrine—Dyspepsia—Docetaxel—ovarian cancer	0.0017	0.00314	CcSEcCtD
Ephedrine—Decreased appetite—Docetaxel—ovarian cancer	0.00168	0.0031	CcSEcCtD
Ephedrine—Pain—Docetaxel—ovarian cancer	0.00165	0.00305	CcSEcCtD
Ephedrine—Arrhythmia—Epirubicin—ovarian cancer	0.00164	0.00302	CcSEcCtD
Ephedrine—Asthenia—Paclitaxel—ovarian cancer	0.00164	0.00301	CcSEcCtD
Ephedrine—Feeling abnormal—Docetaxel—ovarian cancer	0.00159	0.00293	CcSEcCtD
Ephedrine—Selegiline—ABCB1—ovarian cancer	0.00158	0.0305	CrCbGaD
Ephedrine—Tension—Epirubicin—ovarian cancer	0.00157	0.00289	CcSEcCtD
Ephedrine—Nervousness—Epirubicin—ovarian cancer	0.00155	0.00286	CcSEcCtD
Ephedrine—Muscle spasms—Epirubicin—ovarian cancer	0.00154	0.00283	CcSEcCtD
Ephedrine—Body temperature increased—Docetaxel—ovarian cancer	0.00153	0.00282	CcSEcCtD
Ephedrine—Arrhythmia—Doxorubicin—ovarian cancer	0.00152	0.00279	CcSEcCtD
Ephedrine—Dizziness—Paclitaxel—ovarian cancer	0.00151	0.00278	CcSEcCtD
Ephedrine—Agitation—Epirubicin—ovarian cancer	0.00147	0.0027	CcSEcCtD
Ephedrine—Tension—Doxorubicin—ovarian cancer	0.00145	0.00267	CcSEcCtD
Ephedrine—Vomiting—Paclitaxel—ovarian cancer	0.00145	0.00267	CcSEcCtD
Ephedrine—Rash—Paclitaxel—ovarian cancer	0.00144	0.00265	CcSEcCtD
Ephedrine—Dermatitis—Paclitaxel—ovarian cancer	0.00144	0.00265	CcSEcCtD
Ephedrine—Nervousness—Doxorubicin—ovarian cancer	0.00144	0.00265	CcSEcCtD
Ephedrine—Vertigo—Epirubicin—ovarian cancer	0.00144	0.00264	CcSEcCtD
Ephedrine—Headache—Paclitaxel—ovarian cancer	0.00143	0.00263	CcSEcCtD
Ephedrine—Muscle spasms—Doxorubicin—ovarian cancer	0.00142	0.00262	CcSEcCtD
Ephedrine—Palpitations—Epirubicin—ovarian cancer	0.00141	0.0026	CcSEcCtD
Ephedrine—Asthenia—Docetaxel—ovarian cancer	0.00139	0.00256	CcSEcCtD
Ephedrine—Hypertension—Epirubicin—ovarian cancer	0.00138	0.00254	CcSEcCtD
Ephedrine—Chest pain—Epirubicin—ovarian cancer	0.00136	0.00251	CcSEcCtD
Ephedrine—Agitation—Doxorubicin—ovarian cancer	0.00136	0.0025	CcSEcCtD
Ephedrine—Anxiety—Epirubicin—ovarian cancer	0.00136	0.0025	CcSEcCtD
Ephedrine—Nausea—Paclitaxel—ovarian cancer	0.00136	0.0025	CcSEcCtD
Ephedrine—Vertigo—Doxorubicin—ovarian cancer	0.00133	0.00245	CcSEcCtD
Ephedrine—Confusional state—Epirubicin—ovarian cancer	0.00132	0.00242	CcSEcCtD
Ephedrine—Palpitations—Doxorubicin—ovarian cancer	0.00131	0.00241	CcSEcCtD
Ephedrine—Dizziness—Docetaxel—ovarian cancer	0.00128	0.00236	CcSEcCtD
Ephedrine—Hypertension—Doxorubicin—ovarian cancer	0.00128	0.00235	CcSEcCtD
Ephedrine—Tachycardia—Epirubicin—ovarian cancer	0.00127	0.00234	CcSEcCtD
Ephedrine—Hyperhidrosis—Epirubicin—ovarian cancer	0.00126	0.00232	CcSEcCtD
Ephedrine—Chest pain—Doxorubicin—ovarian cancer	0.00126	0.00232	CcSEcCtD
Ephedrine—Anxiety—Doxorubicin—ovarian cancer	0.00126	0.00231	CcSEcCtD
Ephedrine—Anorexia—Epirubicin—ovarian cancer	0.00124	0.00229	CcSEcCtD
Ephedrine—Vomiting—Docetaxel—ovarian cancer	0.00123	0.00226	CcSEcCtD
Ephedrine—Rash—Docetaxel—ovarian cancer	0.00122	0.00225	CcSEcCtD
Ephedrine—Dermatitis—Docetaxel—ovarian cancer	0.00122	0.00224	CcSEcCtD
Ephedrine—Confusional state—Doxorubicin—ovarian cancer	0.00122	0.00224	CcSEcCtD
Ephedrine—Headache—Docetaxel—ovarian cancer	0.00121	0.00223	CcSEcCtD
Ephedrine—Insomnia—Epirubicin—ovarian cancer	0.00118	0.00217	CcSEcCtD
Ephedrine—Tachycardia—Doxorubicin—ovarian cancer	0.00118	0.00217	CcSEcCtD
Ephedrine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00117	0.00215	CcSEcCtD
Ephedrine—Dyspnoea—Epirubicin—ovarian cancer	0.00116	0.00214	CcSEcCtD
Ephedrine—Anorexia—Doxorubicin—ovarian cancer	0.00115	0.00212	CcSEcCtD
Ephedrine—Nausea—Docetaxel—ovarian cancer	0.00115	0.00212	CcSEcCtD
Ephedrine—Dyspepsia—Epirubicin—ovarian cancer	0.00115	0.00211	CcSEcCtD
Ephedrine—Decreased appetite—Epirubicin—ovarian cancer	0.00113	0.00209	CcSEcCtD
Ephedrine—Pain—Epirubicin—ovarian cancer	0.00112	0.00205	CcSEcCtD
Ephedrine—Insomnia—Doxorubicin—ovarian cancer	0.00109	0.00201	CcSEcCtD
Ephedrine—Dyspnoea—Doxorubicin—ovarian cancer	0.00108	0.00198	CcSEcCtD
Ephedrine—Feeling abnormal—Epirubicin—ovarian cancer	0.00108	0.00198	CcSEcCtD
Ephedrine—Dyspepsia—Doxorubicin—ovarian cancer	0.00106	0.00196	CcSEcCtD
Ephedrine—Decreased appetite—Doxorubicin—ovarian cancer	0.00105	0.00193	CcSEcCtD
Ephedrine—Pain—Doxorubicin—ovarian cancer	0.00103	0.0019	CcSEcCtD
Ephedrine—Body temperature increased—Epirubicin—ovarian cancer	0.00103	0.0019	CcSEcCtD
Ephedrine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000995	0.00183	CcSEcCtD
Ephedrine—Body temperature increased—Doxorubicin—ovarian cancer	0.000955	0.00176	CcSEcCtD
Ephedrine—Asthenia—Epirubicin—ovarian cancer	0.000936	0.00172	CcSEcCtD
Ephedrine—Asthenia—Doxorubicin—ovarian cancer	0.000866	0.00159	CcSEcCtD
Ephedrine—Dizziness—Epirubicin—ovarian cancer	0.000863	0.00159	CcSEcCtD
Ephedrine—Vomiting—Epirubicin—ovarian cancer	0.00083	0.00153	CcSEcCtD
Ephedrine—Rash—Epirubicin—ovarian cancer	0.000823	0.00151	CcSEcCtD
Ephedrine—Dermatitis—Epirubicin—ovarian cancer	0.000822	0.00151	CcSEcCtD
Ephedrine—Headache—Epirubicin—ovarian cancer	0.000818	0.0015	CcSEcCtD
Ephedrine—Dizziness—Doxorubicin—ovarian cancer	0.000799	0.00147	CcSEcCtD
Ephedrine—Nausea—Epirubicin—ovarian cancer	0.000775	0.00143	CcSEcCtD
Ephedrine—Vomiting—Doxorubicin—ovarian cancer	0.000768	0.00141	CcSEcCtD
Ephedrine—Rash—Doxorubicin—ovarian cancer	0.000761	0.0014	CcSEcCtD
Ephedrine—Dermatitis—Doxorubicin—ovarian cancer	0.000761	0.0014	CcSEcCtD
Ephedrine—Headache—Doxorubicin—ovarian cancer	0.000757	0.00139	CcSEcCtD
Ephedrine—Nausea—Doxorubicin—ovarian cancer	0.000717	0.00132	CcSEcCtD
Ephedrine—BCHE—Phospholipid metabolism—PIK3CB—ovarian cancer	0.000283	0.00241	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—TUBB3—ovarian cancer	0.00028	0.00238	CbGpPWpGaD
Ephedrine—ACHE—Phospholipid metabolism—PTEN—ovarian cancer	0.000274	0.00233	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.00027	0.0023	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HSD17B6—ovarian cancer	0.000267	0.00227	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—ATF3—ovarian cancer	0.000265	0.00226	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000258	0.0022	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000248	0.00211	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000246	0.0021	CbGpPWpGaD
Ephedrine—BCHE—Phospholipid metabolism—PTEN—ovarian cancer	0.000244	0.00208	CbGpPWpGaD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000243	0.00207	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—ATF3—ovarian cancer	0.000236	0.00201	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYTB—ovarian cancer	0.00023	0.00195	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000229	0.00195	CbGpPWpGaD
Ephedrine—ADRA1A—AMPK Signaling—PIK3CA—ovarian cancer	0.000228	0.00194	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000228	0.00194	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DLC1—ovarian cancer	0.000227	0.00193	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000225	0.00191	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000224	0.00191	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HSD17B6—ovarian cancer	0.000221	0.00188	CbGpPWpGaD
Ephedrine—ADRA1A—AMPK Signaling—TP53—ovarian cancer	0.00022	0.00188	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00022	0.00187	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.00022	0.00187	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000219	0.00186	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000217	0.00185	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (12/13) signalling events—PIK3CA—ovarian cancer	0.000213	0.00182	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000211	0.0018	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYTB—ovarian cancer	0.000205	0.00174	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—ovarian cancer	0.000205	0.00174	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPP1CC—ovarian cancer	0.000201	0.00171	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—BRIP1—ovarian cancer	0.000201	0.00171	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.0002	0.0017	CbGpPWpGaD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000195	0.00166	CbGpPWpGaD
Ephedrine—ACHE—Phospholipid metabolism—PIK3CA—ovarian cancer	0.000193	0.00165	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000191	0.00162	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DLC1—ovarian cancer	0.000188	0.0016	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—MAPK1—ovarian cancer	0.000186	0.00159	CbGpPWpGaD
Ephedrine—ADRA1A—AMPK Signaling—AKT1—ovarian cancer	0.000186	0.00159	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—BCL9—ovarian cancer	0.000185	0.00157	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.00018	0.00154	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPP1CC—ovarian cancer	0.000179	0.00152	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—BRIP1—ovarian cancer	0.000179	0.00152	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000175	0.00149	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000174	0.00148	CbGpPWpGaD
Ephedrine—BCHE—Phospholipid metabolism—PIK3CA—ovarian cancer	0.000172	0.00147	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000172	0.00146	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000172	0.00146	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000165	0.00141	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000162	0.00138	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BCL9—ovarian cancer	0.000153	0.0013	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—HRAS—ovarian cancer	0.00015	0.00127	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000149	0.00127	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000148	0.00126	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000146	0.00125	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DOK1—ovarian cancer	0.000146	0.00124	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000144	0.00123	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PPP1CC—ovarian cancer	0.000137	0.00117	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—YAP1—ovarian cancer	0.000135	0.00115	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000133	0.00113	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000133	0.00113	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.00013	0.00111	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.00013	0.0011	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—MAPK1—ovarian cancer	0.000127	0.00108	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.000122	0.00104	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DOK1—ovarian cancer	0.000121	0.00103	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—YAP1—ovarian cancer	0.00012	0.00102	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000119	0.00101	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000119	0.00101	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000117	0.000997	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—ovarian cancer	0.000116	0.000989	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PPP1CC—ovarian cancer	0.000114	0.000968	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—MAPK1—ovarian cancer	0.000113	0.000963	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	0.000111	0.000947	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—FASN—ovarian cancer	0.00011	0.000934	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SLC5A5—ovarian cancer	0.000108	0.000919	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000107	0.000913	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	0.000106	0.000901	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	0.000106	0.000901	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000104	0.000889	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SLC2A1—ovarian cancer	0.000104	0.000888	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HDAC6—ovarian cancer	0.000104	0.000887	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000103	0.000875	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—PIK3CA—ovarian cancer	0.000103	0.000874	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000102	0.000869	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—MMP2—ovarian cancer	0.000102	0.000868	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—HRAS—ovarian cancer	0.000102	0.000867	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	9.99e-05	0.000851	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYP1B1—ovarian cancer	9.99e-05	0.000851	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CXCL8—ovarian cancer	9.87e-05	0.00084	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—FASN—ovarian cancer	9.79e-05	0.000833	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SLC5A5—ovarian cancer	9.63e-05	0.00082	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SLC2A1—ovarian cancer	9.3e-05	0.000792	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—YAP1—ovarian cancer	9.22e-05	0.000785	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	9.18e-05	0.000782	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.1e-05	0.000775	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—MMP2—ovarian cancer	9.1e-05	0.000775	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—HRAS—ovarian cancer	9.08e-05	0.000773	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—XIAP—ovarian cancer	9.03e-05	0.000769	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP1B1—ovarian cancer	8.91e-05	0.000759	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPP2R1A—ovarian cancer	8.86e-05	0.000755	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.82e-05	0.000751	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SMARCA4—ovarian cancer	8.8e-05	0.000749	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HDAC6—ovarian cancer	8.61e-05	0.000734	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EREG—ovarian cancer	8.59e-05	0.000731	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PPP2R1A—ovarian cancer	8.5e-05	0.000724	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	8.49e-05	0.000723	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CXCL8—ovarian cancer	8.47e-05	0.000722	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ABCB1—ovarian cancer	8.23e-05	0.000701	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCL8—ovarian cancer	8.16e-05	0.000695	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	8.13e-05	0.000692	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—TYMS—ovarian cancer	8.08e-05	0.000688	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PGR—ovarian cancer	8.05e-05	0.000685	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPP2R1A—ovarian cancer	7.91e-05	0.000673	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.87e-05	0.00067	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CTNNB1—ovarian cancer	7.82e-05	0.000666	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—YAP1—ovarian cancer	7.62e-05	0.000649	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CG—ovarian cancer	7.57e-05	0.000645	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CXCL8—ovarian cancer	7.56e-05	0.000644	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PARP1—ovarian cancer	7.48e-05	0.000637	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—XIAP—ovarian cancer	7.47e-05	0.000636	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ABCB1—ovarian cancer	7.34e-05	0.000625	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SMARCA4—ovarian cancer	7.28e-05	0.00062	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—TYMS—ovarian cancer	7.21e-05	0.000614	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6ST—ovarian cancer	7.16e-05	0.000609	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EREG—ovarian cancer	7.1e-05	0.000605	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CTNNB1—ovarian cancer	6.97e-05	0.000594	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CG—ovarian cancer	6.88e-05	0.000586	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PGR—ovarian cancer	6.66e-05	0.000567	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CD—ovarian cancer	6.66e-05	0.000567	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CAV1—ovarian cancer	6.51e-05	0.000555	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CG—ovarian cancer	6.26e-05	0.000533	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.22e-05	0.00053	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PARP1—ovarian cancer	6.19e-05	0.000527	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PPP2R1A—ovarian cancer	6.07e-05	0.000517	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CD—ovarian cancer	6.04e-05	0.000515	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CG—ovarian cancer	5.93e-05	0.000505	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6ST—ovarian cancer	5.92e-05	0.000504	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CAV1—ovarian cancer	5.81e-05	0.000495	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CB—ovarian cancer	5.8e-05	0.000494	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CG—ovarian cancer	5.69e-05	0.000484	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCL8—ovarian cancer	5.58e-05	0.000475	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.55e-05	0.000473	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CD—ovarian cancer	5.51e-05	0.000469	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—IL2—ovarian cancer	5.33e-05	0.000454	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CG—ovarian cancer	5.29e-05	0.000451	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CB—ovarian cancer	5.27e-05	0.000449	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CD—ovarian cancer	5.21e-05	0.000444	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCL8—ovarian cancer	5.06e-05	0.000431	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PPP2R1A—ovarian cancer	5.02e-05	0.000427	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CD—ovarian cancer	5e-05	0.000426	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL2—ovarian cancer	4.84e-05	0.000412	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TERT—ovarian cancer	4.82e-05	0.000411	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CB—ovarian cancer	4.8e-05	0.000409	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CD—ovarian cancer	4.65e-05	0.000396	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCL8—ovarian cancer	4.61e-05	0.000393	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CB—ovarian cancer	4.54e-05	0.000387	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CAV1—ovarian cancer	4.46e-05	0.00038	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—IL2—ovarian cancer	4.41e-05	0.000375	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CB—ovarian cancer	4.36e-05	0.000371	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ESR1—ovarian cancer	4.3e-05	0.000366	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6ST—ovarian cancer	4.23e-05	0.00036	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCL8—ovarian cancer	4.19e-05	0.000357	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CG—ovarian cancer	4.06e-05	0.000346	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APC—ovarian cancer	4.06e-05	0.000346	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—NRAS—ovarian cancer	4.06e-05	0.000346	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CB—ovarian cancer	4.05e-05	0.000345	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL2—ovarian cancer	4e-05	0.000341	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TERT—ovarian cancer	3.99e-05	0.00034	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTEN—ovarian cancer	3.93e-05	0.000334	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MAPK3—ovarian cancer	3.89e-05	0.000331	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MAPK1—ovarian cancer	3.7e-05	0.000315	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EGFR—ovarian cancer	3.7e-05	0.000315	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CAV1—ovarian cancer	3.69e-05	0.000314	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CD—ovarian cancer	3.57e-05	0.000304	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ESR1—ovarian cancer	3.55e-05	0.000303	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CA—ovarian cancer	3.54e-05	0.000301	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTEN—ovarian cancer	3.5e-05	0.000298	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6ST—ovarian cancer	3.5e-05	0.000298	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—KRAS—ovarian cancer	3.5e-05	0.000298	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APC—ovarian cancer	3.36e-05	0.000286	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CG—ovarian cancer	3.36e-05	0.000286	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—NRAS—ovarian cancer	3.36e-05	0.000286	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MAPK3—ovarian cancer	3.22e-05	0.000274	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CA—ovarian cancer	3.21e-05	0.000274	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ERBB2—ovarian cancer	3.15e-05	0.000269	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CB—ovarian cancer	3.11e-05	0.000265	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MTOR—ovarian cancer	3.11e-05	0.000265	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MAPK1—ovarian cancer	3.06e-05	0.000261	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EGFR—ovarian cancer	3.06e-05	0.000261	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCL8—ovarian cancer	2.99e-05	0.000255	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—HRAS—ovarian cancer	2.97e-05	0.000253	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CD—ovarian cancer	2.95e-05	0.000252	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—ovarian cancer	2.93e-05	0.000249	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN1B—ovarian cancer	2.92e-05	0.000249	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—KRAS—ovarian cancer	2.89e-05	0.000246	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT1—ovarian cancer	2.89e-05	0.000246	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP3—ovarian cancer	2.86e-05	0.000244	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL2—ovarian cancer	2.86e-05	0.000243	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6—ovarian cancer	2.84e-05	0.000242	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCND1—ovarian cancer	2.79e-05	0.000237	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CA—ovarian cancer	2.77e-05	0.000236	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CTNNB1—ovarian cancer	2.76e-05	0.000235	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP9—ovarian cancer	2.71e-05	0.00023	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTEN—ovarian cancer	2.69e-05	0.000229	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CA—ovarian cancer	2.66e-05	0.000226	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT1—ovarian cancer	2.62e-05	0.000223	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ERBB2—ovarian cancer	2.61e-05	0.000222	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MTOR—ovarian cancer	2.57e-05	0.000219	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CB—ovarian cancer	2.57e-05	0.000219	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL8—ovarian cancer	2.47e-05	0.000211	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CA—ovarian cancer	2.47e-05	0.00021	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—HRAS—ovarian cancer	2.46e-05	0.000209	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFA—ovarian cancer	2.43e-05	0.000207	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN1B—ovarian cancer	2.42e-05	0.000206	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT3—ovarian cancer	2.41e-05	0.000205	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NRAS—ovarian cancer	2.4e-05	0.000204	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT1—ovarian cancer	2.39e-05	0.000204	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP3—ovarian cancer	2.37e-05	0.000202	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL2—ovarian cancer	2.36e-05	0.000201	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6—ovarian cancer	2.35e-05	0.0002	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCND1—ovarian cancer	2.3e-05	0.000196	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK3—ovarian cancer	2.3e-05	0.000196	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CTNNB1—ovarian cancer	2.28e-05	0.000194	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AKT1—ovarian cancer	2.26e-05	0.000193	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP9—ovarian cancer	2.24e-05	0.000191	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MYC—ovarian cancer	2.24e-05	0.00019	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTEN—ovarian cancer	2.22e-05	0.000189	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK1—ovarian cancer	2.19e-05	0.000186	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGFR—ovarian cancer	2.19e-05	0.000186	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	2.17e-05	0.000185	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KRAS—ovarian cancer	2.07e-05	0.000176	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AKT1—ovarian cancer	2.02e-05	0.000172	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	2.01e-05	0.000171	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	1.99e-05	0.000169	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	1.98e-05	0.000169	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	1.9e-05	0.000162	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CA—ovarian cancer	1.9e-05	0.000162	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MYC—ovarian cancer	1.85e-05	0.000157	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TP53—ovarian cancer	1.84e-05	0.000156	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	1.81e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	1.81e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HRAS—ovarian cancer	1.76e-05	0.000149	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	1.71e-05	0.000145	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6—ovarian cancer	1.68e-05	0.000143	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	1.57e-05	0.000134	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT1—ovarian cancer	1.55e-05	0.000132	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TP53—ovarian cancer	1.52e-05	0.000129	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	1.45e-05	0.000124	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6—ovarian cancer	1.39e-05	0.000118	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	1.28e-05	0.000109	CbGpPWpGaD
